Compare GBIO & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBIO | LANV |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 223.4M |
| IPO Year | 2020 | N/A |
| Metric | GBIO | LANV |
|---|---|---|
| Price | $5.70 | $1.98 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.88 | N/A |
| AVG Volume (30 Days) | ★ 65.6K | 40.3K |
| Earning Date | 11-05-2025 | 08-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,270,000.00 | ★ $341,783,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.00 | $1.38 |
| 52 Week High | $12.40 | $2.69 |
| Indicator | GBIO | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 51.34 |
| Support Level | $5.40 | $1.79 |
| Resistance Level | $5.69 | $2.03 |
| Average True Range (ATR) | 0.22 | 0.20 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 87.72 | 63.64 |
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.